Proton Therapy Market: By Type of System (Single Room System and Multi-Room System), By Application (Paediatric Cancer, Head and neck Cancer, Prostate Cancer, Lung Cancer, Gastro-Intestinal Cancer, Brain Cancer, and Others), By End-User (Hospitals, Radiotherapy Centers and Others) and Geography.  

Proton Therapy Market size was valued at USD 454.14 million in 2022 and is expected to reach USD 1,084.90 million by 2029 at a CAGR of 11.5% during the forecast period 2023-2029. Proton therapy is also known as proton beam radiation therapy. Proton is a positively charged particle, and in high energy levels, protons can destroy cancer cells. Proton therapy is a non-invasive procedure in which proton radiation is used to treat cancer. Proton therapy is a type of external beam radiation therapy, that painlessly delivers radiation through the skin from outside of the body. For the treatment of cancer, proton therapy may be prescribed alone or along with other treatments such as surgery, chemotherapy, general radiation therapy, and or immunotherapy. The global proton therapy market is expected to grow at significant CAGR rates during the forecast period owing to factors such as the growing prevalence of cancer and the adaptation of non-invasive techniques such as radiation therapy to treat the cancer tumors. 

Proton Therapy Market key developments: 

• In September 2017, Elekta and Ion Beam Applications (IBA) has entered into a collaboration to work closely together in software development as well as sales and marketing of each other products.